Biomarkers in Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBeth Israel Deaconess Medical Center
About this trial
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 18 years of age or older
Confirmed or suspected infection
Age 18 years of age or older
A non-infectious clinical presentation to include
Disqualifiers
None
Trial population
Patients presenting to the Emergency Department with suspected infection as well as a non-infected control population.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
4,200 Participants
are grouped into 2 trial groupsGroup A: Infected Group
Group B: Non-infected group
Trial outcomes
Primary outcomes
1
28 day in-hospital mortality
participants will be followed up for 28 days
Time frame
within 28 days after inclusionSecondary outcomes
1
Organ Dysfunction assessed by Sepsis-related Organ Failure Assessment (SOFA) Score
Time frame
within 24 hoursSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov